ResearcherChina Medical UniversityNo recent work listed

Heng-Hsiung Wu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102367537. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper

Papers 1

Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer. Last author DOI 10.1038/s41598-020-73659-z ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lung‐Hung Tsai · 1 shared paper, 2020 · strength 0.11
- Paper Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic can… DOI 10.1038/s41598-020-73659-z ↗
Yu-Huei Liu · 1 shared paper, 2020 · strength 0.11
- Paper Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic can… DOI 10.1038/s41598-020-73659-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.